Clinical Trials Logo

Cognition clinical trials

View clinical trials related to Cognition.

Filter by:

NCT ID: NCT01108679 Completed - HIV Infections Clinical Trials

Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users

Start date: December 1, 2009
Phase:
Study type: Observational

The purpose of this study is to examine how Buprenorphine, a form of opioid addiction treatment, changes the ability to think and reason among people addicted to opiates, who are either HIV negative or HIV positive. In addition, blood samples will be stored for HIV+ and HIV- individuals who take buprenorphine to study its effect. This study hypothesizes that the HIV positive participants will demonstrate significant improvement in thinking and reasoning ability at 3 and 6 months compared to baseline, but that their thinking and reasoning ability will still be lower than HIV negative participants. This study also hypothesizes the biomarkers in participants' blood samples will be associated with measures of change in thinking and reasoning ability.

NCT ID: NCT01079468 Completed - Cognition Clinical Trials

Cognition in Postoperative Total Hip Arthroplasty and Total Hip Resurfacing Patients

Start date: January 2010
Phase: N/A
Study type: Observational

Transient cognitive changes after surgery may be due to many different factors. It is estimated that between 5-29% of patients undergoing orthopedic surgery experience a transient decline in their cognition. Fat and bone marrow debris embolization can cause cognitive changes if they enter the cerebral circulation in significant numbers. During total hip arthroplasty the placement of the femoral stem leads to a rise in intramedullary pressure which can cause fat and bone marrow debris to embolize into the systemic circulation. Total hip resurfacing arthroplasty avoids entrance into the femoral canal. The purpose of this study is to assess transient cognitive changes after total hip arthroplasty and compare them to patients undergoing total hip resurfacing arthroplasty. We hypothesize that patients undergoing total hip resurfacing arthroplasty will experience less transient cognitive changes due to the avoidance of violating the femoral canal during the procedure.

NCT ID: NCT01073228 Completed - Alzheimer's Disease Clinical Trials

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Start date: April 2010
Phase: Phase 2
Study type: Interventional

This study is being conducted to determine the safety and effect on cognitive function of the investigational medication, EVP-6124, in individuals with mild to moderate probable Alzheimer's disease.

NCT ID: NCT01055418 Completed - Cognition Clinical Trials

Cognitive and Cerebral Blood Flow Effects of Vitamin C

Start date: January 2010
Phase: Phase 4
Study type: Interventional

This investigation is interested in the effects of high dose vitamin C on endothelial function in healthy humans. A high fat meal will be utilized to induce endothelial dysfunction. It is hypothesized that, via antioxidant actions, vitamin C will reverse these effects and in turn improve blood flow- the involvement of nitric oxide suggests that this could extend to cerebral blood flow. This will be monitored by trans cranial doppler flow meter and near infrared spectroscopy.

NCT ID: NCT01044342 Completed - Cognition Clinical Trials

A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition

Start date: December 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if cognitive impairment induced by scopolamine is reversed using donepezil and/or AZD1446 as compared to placebo, as assessed by electroencephalogram (EEG) measures.

NCT ID: NCT00989040 Completed - Cognition Clinical Trials

Impact of Neuropathic Post-Zosterian Pain on the Cognition

Start date: March 2009
Phase: Phase 1
Study type: Observational

Pain is defined as a sensorial and emotional phenomenon and lead consequences on the cognition. These consequences could be increased with usual treatment. So the aim of this study is to explore these cognitive consequences.

NCT ID: NCT00968851 Completed - Schizophrenia Clinical Trials

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

Start date: December 2009
Phase: Phase 2
Study type: Interventional

This study is being conducted to determine the safety and effect on cognitive function of two different doses of an investigational medication, EVP-6124, in individuals with schizophrenia who are on chronic stable atypical anti-psychotic therapy. In addition, behavioral and psychotic symptoms will be evaluated.

NCT ID: NCT00924300 Completed - Cognition Clinical Trials

Study to Test the Usefulness of Magnetoencephalography (MEG) Imaging of Cognition in Children and Adolescents

Start date: July 15, 2009
Phase:
Study type: Observational

The primary objective of this protocol is to test the feasibility and utility of obtaining magnetoencephalography (MEG) recordings in healthy children and also in children who have a psychiatric or developmental disorder. Secondary objectives are to examine and compare typical and atypical motor, sensory, and cognitive functioning as recorded by MEG, and to identify subpopulation groups for which MEG may be optimal in order to establish feasibility of future hypothesis-driven MEG research.

NCT ID: NCT00879203 Completed - Cognition Clinical Trials

Glycemic Control, Brain Structure and Cognition in Youth With Type 1 Diabetes (T1DM)

LO5/HY5
Start date: November 2008
Phase: N/A
Study type: Observational

LO5 study: The investigators are inviting a new group of youth (ages 7-16) who have been recently diagnosed with type 1 diabetes and their non-diabetic siblings. These youth will complete cognitive tests and a MRI scan of the brain. This scan uses strong magnets to obtain pictures and does not involve any radiation or injections. The investigators will recruit patients within three months of their diagnosis date. The study entails 1 study visit that lasts 3.5 hours. Evening and weekend times are available. The investigators plan to enroll 135 participants. HY5 study: The investigators are inviting a cohort of youth and young adults (ages 9-21) with type 1 diabetes and their non-diabetic siblings for a follow-up to a study they have already completed. This group of people will complete several memory and thinking tests along with several MRI scans of their brain, just as they did at their previous visits. The investigators plan to enroll 150 participants.

NCT ID: NCT00846950 Completed - Cognition Clinical Trials

Effects of H1-Antagonist on Cognition

Start date: December 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether histamine is involved in memory and specific processes in human cognition.